Mission

As part of the Canadian contribution to the International Collaborative Research Strategy for Alzheimer’s disease, CCNA brings together Canadian government agencies (federal and provincial), foundations, pharmaceutical companies, philanthropists, and international stakeholders to identify whether there are common causes and risk factors to neurodegenerative diseases.

Structure & Governance

CCNA will be led by one nominated principal investigator, supported by three principal investigators for each of the three research themes: Primary Prevention, Secondary Prevention, and Quality of Life.

Financing

The consortium receives C$31.5 million from the federal government and several partners (such as the Alzheimer Society of Canada, which contributes C$4.0 million), as well as an additional C$24.0 million from partners in Ontario and Quebec.

Intellectual Property

Intellectual property guidelines follow those for any grant issued by the Canadian Institutes of Health Research (CIHR). Specifically, CIHR does not retain or claim any ownership of, or exploitation or proprietary rights to, intellectual property, copyright, or inventions developed/resulting from research supported with grant funds and does not pass judgment on the eventual commercial success of the research.

Should grantees decide to pursue commercialization of any results of the research, including all partnered initiatives, they must adhere to institutional and CIHR policies governing the assignment of intellectual property. 

Patient Engagement

The Alzheimer Society of Canada and Alzheimer’s Research UK are founders and financial contributors to the consortium.

Links/Social Media Feed

Points of Contact

Joanne Goldberg
Assistant Director
CIHR Institute of Aging
phone: 514-360-2433
email: joanne.goldberg@criugm.qc.ca

Michelle Peel
Assistant Director
CIHR Institute of Aging
phone: 613-952-4537
email: michelle.peel@cihr-irsc.gc.ca

Sponsors & Partners